Search results for "drug interactions"

showing 10 items of 229 documents

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism

2003

Drug metabolism is the major determinant of drug clearance and, because of polymorphic or inducible expression of drug-metabolising cytochrome P450s (CYPs), is the factor most frequently responsible for interindividual differences in pharmacokinetics. A number of well characterised CYP substrates and inhibitors have been identified that allow precise measurements of individual CYP isoforms. Their use, alone or in combination, facilitates the phenotype characterisation of hepatocytes in vitro and in vivo. Two procedures are used for in vitro investigation of the metabolic profile of a drug: incubation with microsomes and incubation with metabolically competent cells. The major limitation of …

PharmacologybiologyCytochrome P450In Vitro TechniquesIsozymeIn vitroRatsCytochrome P-450 Enzyme SystemPharmaceutical PreparationsBiochemistryIn vivoMolecular Probesbiology.proteinMicrosomeAnimalsCytochrome P-450 Enzyme InhibitorsHumansDrug InteractionsPharmacology (medical)Enzyme InhibitorsEnzyme inducerAntibodies BlockingCytochrome P-450 Enzyme InhibitorsDrug metabolismClinical Pharmacokinetics
researchProduct

Toxicities by herbal medicines with emphasis to traditional Chinese medicine.

2011

It is estimated that three quarters of the world population rely on herbal and traditional medicine as a basis for primary health care. Therefore, it is one of the most important and challenging tasks for scientists working in drug research to investigate the efficacy of herbal medicine, to dissect favorable from adverse effects, to identify active principles in medicinal plants and to ban poisonous plants or contaminations from herbal mixtures. In the present review, some problems are critically discussed. Botanical misidentification or mislabeling of plant material can play a role for toxic reactions in humans. Some plant descriptions in traditional herbal medicine (e.g. traditional Chine…

Pharmacologymedicine.medical_specialtyPlants MedicinalDrug ContaminationTraditional medicinebusiness.industryHerbal MedicineClinical BiochemistryAlternative medicineHerb-Drug Interactionsfood and beveragesPoison controlHeavy metalsTraditional Chinese medicinecomplex mixturesmedicinePotential sourceMedicine Chinese TraditionalMedicinal plantsbusinessAdverse effectDrug ContaminationDrugs Chinese HerbalPhytotherapyCurrent drug metabolism
researchProduct

In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for for…

2013

This review summarizes the current knowledge on anatomy and physiology of the human gastrointestinal tract in comparison with that of common laboratory animals (dog, pig, rat and mouse) with emphasis on in vivo methods for testing and prediction of oral dosage form performance. A wide range of factors and methods are considered in addition, such as imaging methods, perfusion models, models for predicting segmental/regional absorption, in vitro in vivo correlations as well as models to investigate the effects of excipients and the role of food on drug absorption. One goal of the authors was to clearly identify the gaps in today's knowledge in order to stimulate further work on refining the e…

Physiologically based pharmacokinetic modellingChemistry PharmaceuticalPharmaceutical ScienceExcipientAdministration OralComputational biologyPharmacologyPharmaceutical formulationModels BiologicalIntestinal absorptionDosage formBiopharmaceuticsExcipientsFood-Drug InteractionsIVIVCSpecies SpecificityIn vivomedicineAnimalsHumansPharmacokineticsPharmaceutical sciencesChemistryReproducibility of ResultsGastrointestinal TractIntestinal AbsorptionPharmaceutical PreparationsModels AnimalGastrointestinal Motilitymedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

2017

In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is…

PhytochemicalsMedicine (miscellaneous)030204 cardiovascular system & hematologyPharmacologyIntestinal absorption0302 clinical medicineRisk FactorsDrug Interactions030212 general & internal medicineRandomized Controlled Trials as TopicNutrition and DieteticsEvidence-Based MedicineOrvostudományok3. Good healthObservational Studies as TopicLiverCardiovascular DiseasesFatty Acids Unsaturatedlipids (amino acids peptides and proteins)nutraceuticalposition papermedicine.medical_specialtyStatinCombination therapymedicine.drug_classKlinikai orvostudományok03 medical and health sciencesMeta-Analysis as TopiclipidmedicineHumansIntensive care medicineLife StyleTriglyceridesDyslipidemiasbusiness.industryProbioticsdyslipidemiaCholesterol HDLEvidence-based medicineCholesterol LDLmedicine.diseaseResidual riskIntestinal AbsorptionrecommendationsDietary SupplementsPosition paperObservational Studies as TopicHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessDyslipidemia
researchProduct

Cutaneous Toxicity Induced by Hibiscus Tea in a Patient Treated with Erlotinib

2017

Pulmonary and Respiratory MedicineHerb-drug interactionsbiologybusiness.industryCutaneous toxicityPharmacologyHibiscusbiology.organism_classification030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisMedicineErlotinibbusinessSkin pathologymedicine.drugJournal of Thoracic Oncology
researchProduct

Use of Catalyst in a 3D-QSAR Study of the Interactions between Flavor Compounds and β-Lactoglobulin

2003

This paper reports a 3D-QSAR study using Catalyst software to explain the nature of interactions between flavor compounds and beta-lactoglobulin. A set of 35 compounds, for which dissociation constants were previously determined by affinity chromatography, was chosen. The set was divided into three subsets. An automated hypothesis generation, using HypoGen software, produced a model that made a valuable estimation of affinity and provided an explanation for the lack of correlation previously observed between the hydrophobicity of terpenes and the affinity for the protein. On the basis of these results, it appears that aroma binding to beta-lactoglobulin is caused by both hydrophobic interac…

Quantitative structure–activity relationshipChemical PhenomenaChemistry PhysicalTerpenesChemistryStereochemistryQuantitative Structure-Activity RelationshipHydrogen BondingLactoglobulinsGeneral ChemistryCatalysisDissociation constantModels ChemicalComputational chemistryOdorantsComputer SimulationDrug InteractionsGeneral Agricultural and Biological SciencesSoftwareFlavorJournal of Agricultural and Food Chemistry
researchProduct

α-Adrenoceptor Interaction of Tetrandrine and Isotetrandrine in the Rat: Functional and Binding Assays

1998

Abstract The action of 1S,1′S-tetrandrine, a bisbenzyltetrahydroisoquinoline alkaloid, on α1-adrenoceptors has been compared with that of its isomer 1R,1′S-isotetrandrine. The work includes binding assays to analyse the affinity of these products for the [3H]prazosin binding site of rat cerebral cortical membranes and functional studies on rat isolated aorta to examine the effects of both alkaloids on intracellular calcium processes related or not to α-adrenoceptor activation. A radioligand receptor-binding study showed that both compounds interacted with the α1-adrenoceptors displacing [3H]prazosin from the specific binding site. The Ki values (inhibition constants) were 0.69±0.12 and 1.6±…

StereochemistryPharmaceutical Sciencechemistry.chemical_elementAorta ThoracicIn Vitro TechniquesBiologyPharmacologyCalciumTritiumBenzylisoquinolinesBinding CompetitiveMuscle Smooth VascularCalcium in biologyNorepinephrinechemistry.chemical_compoundAlkaloidsPrazosinmedicineExtracellularAnimalsDrug InteractionsRats WistarCerebral CortexPharmacologyBinding SitesMolecular StructureAlkaloidBiological activityPrazosinReceptors Adrenergic alphaCalcium Channel BlockersRatsTetrandrinechemistryCalciumFemaleIntracellularMuscle ContractionProtein Bindingmedicine.drugJournal of Pharmacy and Pharmacology
researchProduct

Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I.

2000

Annonaceous acetogenins (ACG) are a wide group of cytotoxic compounds isolated from plants of the Annonaceae family. Some of them are promising candidates to be a future new generation of antitumor drugs due to the ability to inhibit the NADH:ubiquinone oxidoreductase of the respiratory chain (mitochondrial complex I), main gate of the energy production in the cell. ACG are currently being tested on standard antitumor trials although little is known about the structure activity relationship at the molecular level. On recent studies, the relevance of several parts of the molecule for the inhibitory potency has been evaluated. Due to the great diversity of skeletons included in this family of…

StereochemistryRespiratory chainHerb-Drug InteractionsToxicologyMitochondria HeartLactonesOxidoreductaseMultienzyme ComplexesMoleculeMoietyStructure–activity relationshipAnimalsDrug InteractionsNADH NADPH OxidoreductasesEnzyme InhibitorsFuransAlkylChromatography High Pressure Liquidchemistry.chemical_classificationElectron Transport Complex IbiologyPlant ExtractsGeneral Medicinebiology.organism_classificationAntineoplastic Agents PhytogenicchemistryElectron Transport Complex IBiochemistryAnnonaceaeSeedsCattlePhytotherapyChemico-biological interactions
researchProduct

The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir

2019

Chitosan is object of pharmaceutical research as a candidate permeability enhancer. However, chitosan was recently shown to reduce the oral bioavailability of acyclovir in humans. The effect of chitosan on two processes determining the oral bioavailability of acyclovir, bioaccessibility and intestinal absorption, was now investigated. Acyclovir's bioaccessibility was studied using the dynamic TNO gastro-Intestinal Model (TIM-1). Four epithelial models were used for permeability experiments: a Caco-2 cell model in absence and presence of mucus and both rat and porcine excised intestinal segments. Study concentrations of acyclovir (0.8 g/l) and chitosan (1.6 g/l and 4 g/l) were in line with t…

SwineAcyclovirPharmaceutical ScienceBiocompatible Materials02 engineering and technologyPharmacology030226 pharmacology & pharmacyIN-VITRO EVALUATIONIntestinal absorptionChitosanchemistry.chemical_compound0302 clinical medicineDrug InteractionsPharmacology & PharmacyGeneral MedicinePermeation021001 nanoscience & nanotechnologyMOLECULAR-WEIGHTJejunum0210 nano-technologyLife Sciences & BiomedicineBiotechnologyAbsorption (skin)Antiviral AgentsPermeability03 medical and health sciencesOrgan Culture TechniquesIn vivomedicineAnimalsHumansBiologyABSORPTION ENHANCERSChitosanScience & TechnologyIntestinal permeabilityCACO-2Caco-2medicine.diseaseTRANSPORTRatsBioavailabilityMODELIntestinal AbsorptionchemistryCOMMON EXCIPIENTSCaco-2Intestinal tissue segmentsCaco-2 CellsTNO gastro-Intestinal Model (TIM-1)SYSTEMPOORLY ABSORBABLE DRUGSTRACTEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

2010

Drugs derived from natural resources represent a significant segment of the pharmaceutical market as compared to randomly synthesized compounds. It is a goal of drug development programs to design selective ligands that act on single disease targets to obtain highly effective and safe drugs with low side effects. Although this strategy was successful for many new therapies, there is a marked decline in the number of new drugs introduced into clinical practice over the past decades. One reason for this failure may be due to the fact that the pathogenesis of many diseases is rather multi-factorial in nature and not due to a single cause. Phytotherapy, whose therapeutic efficacy is based on th…

Systems biologyClinical BiochemistryPharmaceutical marketHerb-Drug InteractionsPharmacologylaw.inventionMulti targetlawDrug DiscoveryOils VolatileAnimalsHumansDrug InteractionsPharmacologyChemistryPlant ExtractsDrug SynergismPlantsClinical PracticeDrug developmentMolecular MedicinePlant PreparationsPhytotherapySignalling cascadesFunction (biology)PhytotherapyCurrent drug targets
researchProduct